DiaMedica Therapeutics Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $40.8M | $3.0M |
| Jun 2022 | — | $37.7M | $3.1M |
| Sep 2022 | — | $35.1M | $2.8M |
| Dec 2022 | — | $31.8M | $4.7M |
| Mar 2023 | — | $27.0M | $2.1M |
| Jun 2023 | — | $59.7M | $5.8M |
| Sep 2023 | — | $55.6M | $2.2M |
| Dec 2023 | — | $51.1M | $4.5M |
| Mar 2024 | — | $46.3M | $2.1M |
| Jun 2024 | — | $53.4M | $14.1M |
| Sep 2024 | — | $48.0M | $4.1M |
| Dec 2024 | — | $40.7M | $3.0M |
| Mar 2025 | — | $34.0M | $2.6M |
| Jun 2025 | — | $27.2M | $4.1M |
| Sep 2025 | — | $51.6M | $3.3M |
| Dec 2025 | — | $56.1M | $15.6M |
| Mar 2026 | — | $47.2M | $4.9M |
| Jun 2026 | — | $38.3M | $5.1M |